THR-beta agonist 2 diacetate (Compound 3) is a potent THR-beta agonist with potential applications in researching metabolic disorders such as obesity, hyperlipidemia, hypercholesterolemia, and diabetes, as well as other conditions like steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis, and other related diseases and conditions.
Target:
Thyroid hormone receptor(THR)
* VAT and and shipping costs not included. Errors and price changes excepted
